But change is in the air this year as demand for GLP-1 weight-loss drugs, like Ozempic, Wegovy, Mounjaro and Zepbound, is surging, particularly among older Americans, and studies are showing that climbing obesity rates may be slowing
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
Fewer people with type 1 diabetes than type 2 diabetes were on CVD medication (53.9% vs 82.1%), ACE inhibitors (22.5% vs 32.0%) and angiotensin receptor blockers (ARB) (16.7% vs 31.3%)
GLP-1 (Glucagon-Like Peptide-1) is a naturally occurring hormone in your body
Lower starting points (around 1 mg/day) are typical for new research planning, and 2 mg/day is the high end most references cite
The reviewers evaluated the search results and conducted the analysis